To view enhanced digital features for this article go to https://doi.org/10.6084/m9.figshare.7258007.
Traumatic brain injury is a challenge for general practitioners and specialists worldwide due to the heterogeneous clinical picture, secondary injuries and complex treatment including surgery, medication, intensive care, nutrition and rehabilitation. This case report is about a TBI patient with a score of four on the Glasgow Coma Scale when she was transferred from the primary hospital to our center. Her condition, treatment options and expectations were discussed with the relatives. The patient was subjected to surgery and received pharmacologic intervention including a neurotrophic drug and extensive rehabilitation measures including occupational therapy. Considering the patient's remarkable recovery, a combination of multiple treatment approaches seems promising in patients with severe traumatic brain injury.
Theadom A, Feigin V, Reith F, Maas A. Epidemiology of traumatic brain injury. In: Winn HR, editor. Youmans and Winn neurological surgery. Philadelphia: Elsevier; 2017.
Finkelstein E, Corso P, Miller T. The incidence and economic burden of injuries in the United States. New York: Oxford University Press; 2006. CrossRef
Wakai A, McCabe A, Roberts I, Schierhout G. Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev. 2013;8:CD001049.
Olivecrona M, Koskinen LO. The IMPACT prognosis calculator used in patients with severe traumatic brain injury treated with an ICP-targeted therapy. Acta Neurochir (Wien). 2012;154:1567. CrossRef
Grigorakos L, Alexopoulou A, Tzortzopoulou K, Stratouli S, Chroni D. A predictors of outcome in patients with severe traumatic brain injury. J Neurosci Clin Res. 2016;1:1.
Skolnick BE, Maas AI, Narayan RK, et al. A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med. 2014;371:2457. CrossRef
Brain Trauma Foundation TBI Guidelines 2016. Guidelines for the management of severe traumatic brain injury, 4th ed. Neurosurgery 2016;3:p76.
Secades Julio. Citicoline for the treatment of head injury: a systematic review and meta-analysis of controlled clinical trials. J Trauma Treat. 2014;4:227. CrossRef
Zafronte RD, Bagiella E, Ansel BM, et al. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). JAMA. 2012;308:1993–2000. CrossRef
Brain Trauma Foundation TBI Guidelines 2016. Guidelines for the management of severe traumatic brain injury, 4th ed. Neurosurgery 2016;0:3
He J, Fan J, Geng S. Efficacy of cerebrolysin in acute brain trauma. Chin J Clin Pract Med. 2002;4:71–2.
König P, Wannders R, Witzmann A, et al. Cerebrolysin in traumatic brain injury—a pilot study of a neurotrophic and neurogenic agent in the treatment of acute traumatic brain injury. J Neurol Neurochir Psychiatr. 2006;7:12–20.
- Patient and Physician Perspectives in a Case of Severe Traumatic Brain Injury
Rhoderick M. Casis
- Springer Healthcare
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II